MFDS — authorised 20 July 2023
- Marketing authorisation holder: DAIICHI SANKYO INC
- Status: likely_approved
🇰🇷 Vanflyta in South Korea
MFDS authorised Vanflyta on 20 July 2023
Marketing authorisation
Vanflyta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Vanflyta approved in South Korea?
Yes. MFDS authorised it on 20 July 2023.
Who is the marketing authorisation holder for Vanflyta in South Korea?
DAIICHI SANKYO INC holds the South Korean marketing authorisation.